CEO Adeel Dhedhi Bhyria was honored to be invited to share his insights and suggestions on the effective distribution of the potential COVID-19 vaccines at a press briefing held by the Presidential Spokesperson.
CHIEF Executive Officer of SAHAR International Trading Inc. (Sahar Pharma) and President of DEEL Corporation – Adeel Dhedhi Bhyria is a Singaporean businessman of Pakistani descent that has been at the helm of his companies’ robust operations, leading the companies to exponential growth and expansion by introducing innovative and future-ready products and services to their growing portfolio. These include new and upcoming ventures complementary to our existing line of businesses as well as entry in completely new sectors such as biotech and energy” said CEO Adeel Dhedhi Bhyria. In his role, he oversees his companies’ overall visions, strategies, and directions to build the companies into dynamic world- class enterprises with professional and progressive corporate culture and discipline. Fuelling his companies’ growth with a focused management and streamlined operations driven by technology and data, they are always ready to move rapidly in response to customers’ changing needs and demands. Adeel Dhedhi Bhyria sees the current pandemic as a way to expand and better serve the community. “COVID-19 allowed us to take on new challenges for the kind of products and services we provide in the Philippine market. Most importantly, we are still constantly learning and adapting as the situation and technology evolve.” he shared.
“Our product was one of the first RT-PCR kits to be approved by the Food and Drug Administration of the Philippines (FDA). That was one of our initial achievements, where we managed to register our RT- PCR kit for COVID-19 and introduce it to the Philippine market early on, following which we introduced numerous COVID-19 related products. Continuously delivering innovations, Our company was the first to launch Philippine’s first saliva-based antigen rapid test kit and is actively looking at future technologies for further enhancing the testing capabilities nationwide,” said Bhyria.
CEO'S VISION OF THE INNOVATIONS AHEAD
1. Point-of-care Molecular Testing with RT-LAMP
The kit has received Philippines FDA certification and has regulatory approvals with MHRA in the UK (FDA Equivalent) and the CE Mark in the EU. Our results have already been validated and peer- reviewed to perform with 100% sensitivity without requiring a tedious RNA extraction procedure and 100% specificity due to a patent-pending molecular switch.
2. RT-PCR testing using saliva
3. Vaccine & Test Results Registry - Immunity Passport Platform
Vaccine Registry Management System (VRMS)
A Vaccine Registry Management System (VRMS) will provide a low cost system roll out of mass vaccination programs. Patient data can be kept safely with a blockchain based vaccine registry management system. A VRMS is easy to implement and creates a common vaccine tracking system linking private and public healthcare systems. The platform can be designed to provide a long term vaccine management registry system for all diseases requiring testing and vaccination including TB, flu, rabies, MMR etc. All lab tests can be uploaded into the blockchain, preventing fraud and allowing for an electronic verification system with history of all tests done.
Data Protection
Alert System
Tracking Vaccine Doses
Test Results in the blockchain
Testing will still form the primary way in which to manage this and other pandemics. Testing also establishes the ability to determine whether an immune response has occurred post-vaccination. The platform aims to stop the use of unverified tests results and ensure that laboratory testing is not compromised.
Adeel Dhedhi Bhyria believes that the Covid 19 crisis has created an opportunity for us to improve national healthcare systems, and in many cases to provide the first electronic medical registry system. Our vision is that a platform like this with an immunity passport can be used by the Philippines as a trusted way to verify tests results and vaccination status as information will be verified electronically in the blockchain.
In conclusion, the end result of the whole process culminates in an immunity passport, that can be used to access a user’s full electronic testing and vaccination history. Airlines, immigration, hospitals, insurance companies, restaurants, stadiums, schools and universities can access this information by simply scanning a QR code. Thereby allowing safe and quarantine- free travel and resumption of activities – providing the fastest way to open up borders and the economy.
